City of Broken Arrow v. Purdue Pharma L.P. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:19-op-45415 |
| Nature of Suit | 360 Torts - Personal Injury - Other Personal Injury |
| Cause | No cause code entered |
| Case Filed: | Jun 10, 2019 |
| Case in other court: | Oklahoma Northern, 4:19-cv-00047 |
| Last checked: Friday Nov 08, 2019 7:44 PM EST |
|
Defendant
Teva Pharmaceutical Industries Ltd.
|
Represented By
|
|
Defendant
Mallinckrodt PLC
|
|
|
Defendant
McKesson Corp.
|
Represented By
|
|
Defendant
Morris & Dickson Co LLC
|
|
|
Defendant
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Physicians Total Care Inc
|
|
|
Defendant
Russel Portenoy
|
Represented By
|
|
Defendant
Purdue Frederick Company, Inc.
|
Represented By
|
|
Defendant
Purdue Pharma Inc.
|
Represented By
|
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
Quest Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Mallinckrodt LLC
|
Represented By
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
Represented By
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
Watson Pharma, Inc.
|
Represented By
|
|
Defendant
Watson Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Lynn Webster
|
|
|
Defendant
L. & R. Distributors, Inc.
|
|
|
Defendant
Mylan Pharmaceuticals, Inc.
781 Chestnut Ridge Road
Morgantown, WV 26505 |
|
|
Defendant
Par Pharmaceutical Inc.
|
|
|
Defendant
SpecGX LLC
|
|
|
Defendant
Walgreens Boots Alliance, Inc. a/k/a Walgreen Co.
|
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Actavis plc
|
Represented By
|
|
Defendant
Allergan PLC
|
|
|
Defendant
Amerisourcebergen Corp.
|
Represented By
|
|
Defendant
Anda Inc
|
Represented By
|
|
Defendant
Anda Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Cardinal Health Inc.
|
Represented By
|
|
Defendant
Cephalon Inc.
|
Represented By
|
|
Defendant
Endo Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Perry Fine
|
Represented By
|
|
Defendant
GCP Pharma LLC
|
|
|
Defendant
Harvard Drug Company, LLC
|
Represented By
|
|
Defendant
Insys Therapeutics, Inc.
|
Represented By
|
|
Defendant
Janssen Phamaceutica, Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
Keysource Medical, Inc.
|
|
|
Defendant
Joshua Livingston
|
|
|
Plaintiff
City of Broken Arrow
|
Represented By
|
| Docket last updated: 06/17/2019 9:55 AM EDT |
| Monday, January 07, 2019 | ||
| PETITION/COMPLAINT with Jury Demand filed in State Court against All Defendants by City of Broken Arrow (jln, Dpty Clk) [Transferred from oknd on 6/10/2019.] | ||
| Tuesday, January 29, 2019 | ||
| 1 | 1
CIVIL COVER SHEET by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from oknd on 6/10/2019.]
|
|
| 2 | 2
NOTICE of Removal with Jury Demand from District Court of Tulsa County, case number CJ-2019-00063 (paid $400 filing fee; receipt number 1085-2008388) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (With attachments) (Zschiesche, Raymond) [Transferred from oknd on 6/10/2019.]
|
|
| Wednesday, January 30, 2019 | ||
| 3 | 3 MINUTE ORDER by Court Clerk , : Pursuant to Local Rule 81.2, the removing party(ies) shall file a Status Report on Removed Action within five (5) days of the filing of the notice of removal in the U.S. District Court. The form is available on the Court's website. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) [Transferred from oknd on 6/10/2019.] | |
| 4 | 4 MINUTE ORDER by Court Clerk , directing Endo Health Solutions Inc., Endo Pharmaceuticals Inc., McKesson Corp., Cardinal Health, Inc. and AmerisourceBergen Corp. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) [Transferred from oknd on 6/10/2019.] | |
| 5 | 5
ATTORNEY APPEARANCE by D Michael McBride, III on behalf of AmerisourceBergen Corp. (McBride, D) [Transferred from oknd on 6/10/2019.]
|
|
| 6 | 6
ATTORNEY APPEARANCE by Susan E Huntsman on behalf of AmerisourceBergen Corp. (Huntsman, Susan) [Transferred from oknd on 6/10/2019.]
|
|
| 7 | 7
CORPORATE DISCLOSURE STATEMENT by AmerisourceBergen Corp. (Huntsman, Susan) [Transferred from oknd on 6/10/2019.]
|
|
| 8 | 8
ATTORNEY APPEARANCE by Raymond Edward Zschiesche on behalf of Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from oknd on 6/10/2019.]
|
|
| 9 | 9
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Endo International plc for Endo Health Solutions Inc.) by Endo Health Solutions Inc. (Zschiesche, Raymond) [Transferred from oknd on 6/10/2019.]
|
|
| 10 | 10
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Endo International plc for Endo Pharmaceuticals Inc.) by Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from oknd on 6/10/2019.]
|
|
| 11 | 11
ATTORNEY APPEARANCE by Ryan A Ray on behalf of Cardinal Health, Inc. (Ray, Ryan) [Transferred from oknd on 6/10/2019.]
|
|
| 12 | 12
CORPORATE DISCLOSURE STATEMENT by Cardinal Health, Inc. (Ray, Ryan) [Transferred from oknd on 6/10/2019.]
|
|
| Thursday, January 31, 2019 | ||
| 13 | 13
ATTORNEY APPEARANCE by Stuart Douglas Campbell on behalf of McKesson Corp. (Campbell, Stuart) [Transferred from oknd on 6/10/2019.]
|
|
| 14 | 14
CORPORATE DISCLOSURE STATEMENT by McKesson Corp. (Campbell, Stuart) [Transferred from oknd on 6/10/2019.]
|
|
| 15 | 15 MINUTE ORDER by Court Clerk , directing John Lombardo and Tiffany Ikeda to file by 2/21/2019 a Motion for Admission Pro Hac Vice per Local Civil Rule 83.2. Additionally, if you intend to practice in this district in the future and want to become a member of this district, please submit an application for attorney admission. (This entry is the Official Order of the Court. No document is attached.) (eaw, Dpty Clk) [Transferred from oknd on 6/10/2019.] | |
| 16 | 16
STATUS REPORT on Removed Action by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from oknd on 6/10/2019.]
|
|
| 17 | 17
ATTORNEY APPEARANCE by Kaylee Patricia Davis-Maddy on behalf of McKesson Corp. (Davis-Maddy, Kaylee) [Transferred from oknd on 6/10/2019.]
|
|
| Monday, February 04, 2019 | ||
| 18 | 18
Unopposed MOTION for Extension of Time to Answer by AmerisourceBergen Corp., Cardinal Health, Inc., McKesson Corp. (Campbell, Stuart) [Transferred from oknd on 6/10/2019.]
|
|
| Tuesday, February 05, 2019 | ||
| 19 | 19
ORDER by Judge Terence Kern - Defendants McKesson, Cardinal Health, Inc., and AmerisourceBergen Drug Corporation's answer or responsive pleading due 45 days after ruling on any motion to remand or transfer case to MDL Panel. ; granting18 Motion for Extension of Time to Answer (lmc, Chambers) [Transferred from oknd on 6/10/2019.]
|
|
| 20 | 20
ATTORNEY APPEARANCE by John Hunt Sparks on behalf of Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Sparks, John) [Transferred from oknd on 6/10/2019.]
|
|
| 21 | 21
ATTORNEY APPEARANCE by Michael W Ridgeway on behalf of Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Ridgeway, Michael) [Transferred from oknd on 6/10/2019.]
|
|
| 22 | 22
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Janssen Pharmaceuticals, Inc. for Janssen Pharmaceutica, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc.) by Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Ridgeway, Michael) [Transferred from oknd on 6/10/2019.]
|
|
| 23 | 23
Unopposed MOTION for Extension of Time to Answer by Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Ridgeway, Michael) [Transferred from oknd on 6/10/2019.]
|
|
| Wednesday, February 06, 2019 | ||
| 24 | 24
ORDER by Judge Terence Kern - Manufacturer Defendants' answer or responsive pleading due 45 days after ruling on any motion to remand or transfer case to MDL Panel. ; granting23 Motion for Extension of Time to Answer (lmc, Chambers) [Transferred from oknd on 6/10/2019.]
|
|
| 25 | 25
ATTORNEY APPEARANCE by Sanford C Coats on behalf of Purdue Frederick Company, Inc., The, Purdue Pharma Inc., Purdue Pharma L.P. (Coats, Sanford) [Transferred from oknd on 6/10/2019.]
|
|
| 26 | 26
ATTORNEY APPEARANCE by Jennifer Nicole Lamirand on behalf of Purdue Frederick Company, Inc., The, Purdue Pharma Inc., Purdue Pharma L.P. [Note: Attorney Jennifer Nicole Lamirand added to party Purdue Frederick Company, Inc., The(pty:dft), Attorney Jennifer Nicole Lamirand added to party Purdue Pharma Inc.(pty:dft), Attorney Jennifer Nicole Lamirand added to party Purdue Pharma L.P.(pty:dft).] (Lamirand, Jennifer) [Transferred from oknd on 6/10/2019.]
|
|
| Thursday, February 07, 2019 | ||
| 27 | 27 MINUTE ORDER by Court Clerk , directing Janssen Pharmaceutica, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (sc, Dpty Clk) [Transferred from oknd on 6/10/2019.] | |
| 28 | 28
ATTORNEY APPEARANCE by D Todd Riddles on behalf of Quest Pharmaceuticals, Inc. [Note: Attorney D Todd Riddles added to party Quest Pharmaceuticals, Inc.(pty:dft).] (Riddles, D) [Transferred from oknd on 6/10/2019.]
|
|
| 29 | 29
CORPORATE DISCLOSURE STATEMENT by Quest Pharmaceuticals, Inc. (Riddles, D) [Transferred from oknd on 6/10/2019.]
|
|
| 30 | 30
Amended NOTICE of Removal by McKesson Corp. (With attachments) (Campbell, Stuart) Modified on 2/8/2019 to change text to reflect correct event and add link (sac-qc, Dpty Clk). [Transferred from oknd on 6/10/2019.]
|
|
| Friday, February 08, 2019 | ||
| NOTICE of Docket Entry Modification; Error: wrong event selected (Notice - Other); Correction: changed text to reflect correct event (Amended NOTICE of Removal) (sac-qc, Dpty Clk) [Transferred from oknd on 6/10/2019.] | ||
| 31 | 31 MINUTE ORDER by Court Clerk , directing Purdue Frederick Company, Inc., The, Purdue Pharma Inc., Purdue Pharma L.P. [ to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (sc, Dpty Clk) [Transferred from oknd on 6/10/2019.] | |
| 32 | 32
MOTION for Extension of Time to Answer , Move, or Otherwise Respond to Petition under Rule 12 by Quest Pharmaceuticals, Inc. (Riddles, D) [Transferred from oknd on 6/10/2019.]
|
|
| 33 | 33 MINUTE ORDER by Judge Terence Kern - Defendant Quest Pharmaceuticals, Inc.'s Unopposed Motion to Extend Time to Answer, Move or Otherwise Respond to Petition Under Rule 12 (Doc. 32) is hereby granted. The time for Defendant to answer, move or otherwise respond to the Petition is hereby extended until 45 days following (1) a decision by the Judicial Panel on Multidistrict Litigation granting a motion to vacate a conditional transfer order covering this action or otherwise finally denying transfer of this action or (2) this Court's ruling on any motion to remand, whichever is later. ; granting32 Motion for Extension of Time to Answer (This entry is the Official Order of the Court. No document is attached.) (lmc, Chambers) [Transferred from oknd on 6/10/2019.] | |
| 34 | 34
ERRATA/CORRECTION by McKesson Corp. (With attachments) (Campbell, Stuart) [Transferred from oknd on 6/10/2019.]
|
|
| Monday, February 11, 2019 | ||
| 35 | 35 MINUTE ORDER by Court Clerk , directing Quest Pharmaceuticals, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (dlg, Dpty Clk) [Transferred from oknd on 6/10/2019.] | |
| 36 | 36
CORPORATE DISCLOSURE STATEMENT by Purdue Pharma L.P. (Lamirand, Jennifer) [Transferred from oknd on 6/10/2019.]
|
|
| 37 | 37
CORPORATE DISCLOSURE STATEMENT by Purdue Pharma Inc. (Lamirand, Jennifer) [Transferred from oknd on 6/10/2019.]
|
|
| 38 | 38
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Pharmaceutical Research Associates, Inc. for Purdue Frederick Company, Inc., The) by Purdue Frederick Company, Inc., The (Lamirand, Jennifer) [Transferred from oknd on 6/10/2019.]
|
|
| Tuesday, February 12, 2019 | ||
| 39 | 39
ATTORNEY APPEARANCE by Ashley E Quinn on behalf of Actavis LLC, Actavis Pharma, Inc., Cephalon Inc., Teva Pharmaceuticals USA, Inc., Watson Pharma, Inc. [Note: Attorney Ashley E Quinn added to party Actavis LLC(pty:dft), Attorney Ashley E Quinn added to party Actavis Pharma, Inc.(pty:dft), Attorney Ashley E Quinn added to party Cephalon Inc.(pty:dft), Attorney Ashley E Quinn added to party Teva Pharmaceuticals USA, Inc.(pty:dft), Attorney Ashley E Quinn added to party Watson Laboratories, Inc. (pty:dft).] (Quinn, Ashley) Modified on 2/13/2019 - removed filer selected in error (Watson Pharma, Inc.) and added correct filer (Watson Laboratories, Inc.) (srt, Dpty Clk). [Transferred from oknd on 6/10/2019.]
|
|
| 40 | 40
ATTORNEY APPEARANCE by Nicholas Vernon Merkley on behalf of Actavis LLC, Actavis Pharma, Inc., Cephalon Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., [Note: Attorney Nicholas Vernon Merkley added to party Watson Pharma, Inc.(pty:dft).] (Merkley, Nicholas) Modified on 2/13/2019 to remove filer selected in error (Watson Pharma, Inc.) (srt, Dpty Clk). [Transferred from oknd on 6/10/2019.]
|
|
| 41 | 41
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent TEVA Pharmaceuticals Industries, LTD for Actavis LLC, Actavis Pharma, Inc., Cephalon Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.) by Actavis LLC, Actavis Pharma, Inc., Cephalon Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (Merkley, Nicholas) [Transferred from oknd on 6/10/2019.]
|
|
| Wednesday, February 13, 2019 | ||
| NOTICE of Docket Entry Modification; Error: wrong filer selected; Correction: removed filer selected in error (Watson Pharma, Inc.) and added correct filer (Watson Laboratories, Inc.) (srt, Dpty Clk) [Transferred from oknd on 6/10/2019.] | ||
| NOTICE of Docket Entry Modification; Error: filer selected in error (Watson Pharma, Inc.); Correction: removed filer selected in error (srt, Dpty Clk) [Transferred from oknd on 6/10/2019.] | ||
| Thursday, February 14, 2019 | ||
| 42 | 42 MINUTE ORDER by Court Clerk , directing Cephalon Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., Actavis Pharma, Inc., Actavis LLC to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (dlg, Dpty Clk) [Transferred from oknd on 6/10/2019.] | |
| 43 | 43
ATTORNEY APPEARANCE by Lisa Renee Hemphill on behalf of Anda Pharmaceuticals, Inc., Anda, Inc. [Note: Attorney Lisa Renee Hemphill added to party Anda Pharmaceuticals, Inc.(pty:dft), Attorney Lisa Renee Hemphill added to party Anda, Inc.(pty:dft).] (Hemphill, Lisa) [Transferred from oknd on 6/10/2019.]
|
|
| 44 | 44
Unopposed MOTION for Extension of Time to Answer Move, or Otherwise Respond by Anda Pharmaceuticals, Inc., Anda, Inc. (Hemphill, Lisa) [Transferred from oknd on 6/10/2019.]
|
|
| Friday, February 15, 2019 | ||
| 45 | 45
ORDER by Judge Terence Kern regarding Anda Defendants response to Petition. ; granting44 Motion for Extension of Time to Answer (lmc, Chambers) [Transferred from oknd on 6/10/2019.]
|
|
| Tuesday, February 19, 2019 | ||
| 46 | 46 MINUTE ORDER by Court Clerk , directing Anda Pharmaceuticals, Inc. and Anda, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (jln, Dpty Clk) [Transferred from oknd on 6/10/2019.] | |
| Thursday, February 21, 2019 | ||
| 47 | 47
MOTION for Attorney(s) Tiffany M. Ikeda to be Admitted Pro Hac Vice (paid $50 PHV fee; receipt number 1085-2018986) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (With attachments) (Zschiesche, Raymond) [Transferred from oknd on 6/10/2019.]
|
|
| 48 | 48
MOTION for Attorney(s) John D. Lombardo to be Admitted Pro Hac Vice (paid $50 PHV fee; receipt number 1085-2018989) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (With attachments) (Zschiesche, Raymond) [Transferred from oknd on 6/10/2019.]
|
|
| 49 | 49
ORDER by Judge Terence Kern - Tiffany M. Ikeda and John D. Lombardo are admitted Pro Hac Vice for Defendants Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. ; ; granting47 Motion for Admission Pro Hac Vice; granting48 Motion for Admission Pro Hac Vice (lmc, Chambers) [Transferred from oknd on 6/10/2019.]
|
|
| 50 | 50
ATTORNEY APPEARANCE by Jeffrey Allen Curran on behalf of Anda Pharmaceuticals, Inc., Anda, Inc. [Note: Attorney Jeffrey Allen Curran added to party Anda Pharmaceuticals, Inc.(pty:dft), Attorney Jeffrey Allen Curran added to party Anda, Inc.(pty:dft).] (Curran, Jeffrey) [Transferred from oknd on 6/10/2019.]
|
|
| 51 | 51
MOTION to Remand by City of Broken Arrow (With attachments) (Court, Todd) [Transferred from oknd on 6/10/2019.]
|
|
| 52 | 52
MOTION to Accelerate/Extend/Reset Hearing(s)/Deadline(s) (MOTION FOR EXPEDITED BRIEFING) by City of Broken Arrow (Court, Todd) [Transferred from oknd on 6/10/2019.]
|
|
| Friday, February 22, 2019 | ||
| 53 | 53
ORDER by Judge Terence Kern ; setting/resetting deadline(s)/hearing(s): ( Responses due by 2/28/2019, Replies due by 3/4/2019); granting52 Motion to Accelerate/Extend/Reset Hearing(s)/Deadline(s) (lmc, Chambers) [Transferred from oknd on 6/10/2019.]
|
|
| Monday, February 25, 2019 | ||
| 54 | 54
MOTION to Reconsider Order Granting Plaintiff's Motion for Expedited Briefing by AmerisourceBergen Corp., Cardinal Health, Inc., Endo Health Solutions Inc., Endo Pharmaceuticals Inc., McKesson Corp. (Campbell, Stuart) [Transferred from oknd on 6/10/2019.]
|
|
| 55 | 55
Joint MOTION to Stay Proceedings Pending Likely Transfer to Multidistrict Litigation by AmerisourceBergen Corp., Cardinal Health, Inc., McKesson Corp. (With attachments) (Campbell, Stuart) [Transferred from oknd on 6/10/2019.]
|
|
| 56 | 56 MINUTE ORDER by Judge Terence Kern - Defendants' Motion for Reconsideration of Order Granting Plaintiff's Motion for Expedited Briefing (Doc. 54) is hereby granted. Plaintiffs' Motion for Expedited Briefing (Doc. 52) is denied. Defendants' Response to Plaintiff's Motion to Remand (Doc. 51) shall be filed on or before March 14, 2019. Plaintiff may file an expedited Reply if it desires. ; setting/resetting deadline(s)/hearing(s): ( Responses due by 3/14/2019, Replies due by 3/28/2019); granting54 Motion to Reconsider (This entry is the Official Order of the Court. No document is attached.) (lmc, Chambers) [Transferred from oknd on 6/10/2019.] | |
| Wednesday, February 27, 2019 | ||
| 57 | 57
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent TEVA Pharmaceuticals Industries, LTD for Anda Pharmaceuticals, Inc.) by Anda Pharmaceuticals, Inc. (Curran, Jeffrey) [Transferred from oknd on 6/10/2019.]
|
|
| 58 | 58
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent TEVA Pharmaceuticals Industries, LTD for Anda, Inc.) by Anda, Inc. (Curran, Jeffrey) [Transferred from oknd on 6/10/2019.]
|
|
| Tuesday, March 05, 2019 | ||
| 59 | 59
ATTORNEY APPEARANCE by Ryan A Ray on behalf of Harvard Drug Group, LLC, The [Note: Attorney Ryan A Ray added to party Harvard Drug Group, LLC, The(pty:dft).] (Ray, Ryan) [Transferred from oknd on 6/10/2019.]
|
|
| 60 | 60
CORPORATE DISCLOSURE STATEMENT (identifying: Corporate Parent Cardinal Health, Inc., Corporate Parent Generic Drug Holdings, Inc., Corporate Parent HDG Acquisition, Inc., Corporate Parent Cardinal Health 110, LLC for Harvard Drug Group, LLC, The) by Harvard Drug Group, LLC, The (Ray, Ryan) [Transferred from oknd on 6/10/2019.]
|
|
| 61 | 61
Unopposed MOTION for Extension of Time to Answer or File Responsive Pleading by Harvard Drug Group, LLC, The (Ray, Ryan) [Transferred from oknd on 6/10/2019.]
|
|
| Wednesday, March 06, 2019 | ||
| 62 | 62
ORDER by Judge Terence Kern ; granting61 Motion for Extension of Time to Answer (pll, Dpty Clk) [Transferred from oknd on 6/10/2019.]
|
|
| 63 | 63
Amended CORPORATE DISCLOSURE STATEMENT (identifying: Other Affiliate Walgreens Boots Alliance Holdings LLC for AmerisourceBergen Corp.) by AmerisourceBergen Corp. (Huntsman, Susan) [Transferred from oknd on 6/10/2019.]
|
|
| Thursday, March 07, 2019 | ||
| 64 | 64 MINUTE ORDER by Court Clerk , directing Harvard Drug Group, LLC, The to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (dlg, Dpty Clk) [Transferred from oknd on 6/10/2019.] | |
| Thursday, March 14, 2019 | ||
| 65 | 65
RESPONSE in Opposition to Motion by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. ; (Zschiesche, Raymond) [Transferred from oknd on 6/10/2019.]
|
|
| 66 | 66
RESPONSE in Opposition to Motion by McKesson Corp. ; (With attachments) (Campbell, Stuart) [Transferred from oknd on 6/10/2019.]
|
|
| Friday, March 15, 2019 | ||
| 67 | 67
RESPONSE in Opposition to Motion by City of Broken Arrow ; (With attachments) (Court, Todd) [Transferred from oknd on 6/10/2019.]
|
|
| Friday, March 22, 2019 | ||
| 68 | 68
REPLY to Response to Motion by City of Broken Arrow ; (Court, Todd) [Transferred from oknd on 6/10/2019.]
|
|
| Friday, March 29, 2019 | ||
| 69 | 69
Joint REPLY to Response to Motion by AmerisourceBergen Corp., Cardinal Health, Inc., McKesson Corp. ; (Campbell, Stuart) Modified on 4/1/2019 to change text to reflect correct event (sac-qc, Dpty Clk). [Transferred from oknd on 6/10/2019.]
|
|
| Monday, April 01, 2019 | ||
| NOTICE of Docket Entry Modification; Error: wrong event selected (Brief in Support of Motion); Correction: changed text to reflect correct event (sac-qc, Dpty Clk) [Transferred from oknd on 6/10/2019.] | ||
| Monday, April 08, 2019 | ||
| 70 | 70
MOTION for Leave to File Supplemental Authority by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (With attachments) (Zschiesche, Raymond) [Transferred from oknd on 6/10/2019.]
|
|
| Tuesday, April 09, 2019 | ||
| 71 | 71 MINUTE ORDER by Judge Terence Kern ; granting70 Motion for Leave to File Document(s) (This entry is the Official Order of the Court. No document is attached.) (srt, Dpty Clk) [Transferred from oknd on 6/10/2019.] | |
| Tuesday, April 23, 2019 | ||
| 72 | 72 MINUTE ORDER by Court Clerk , directing Steven A Reed, Brian M Ercole, Harvey Bartle IV, Charles C Lifland, J Matthew Donohue, and Joseph L Franco to file by 5/23/2019 a Motion for Admission Pro Hac Vice per Local Civil Rule 83.2. Additionally, if you intend to practice in this district in the future and want to become a member of this district, please submit an application for attorney admission. (This entry is the Official Order of the Court. No document is attached.) (eaw, Dpty Clk) [Transferred from oknd on 6/10/2019.] | |
| Thursday, May 23, 2019 | ||
| 73 | 73
MOTION for Attorney(s) Harvey Bartle to be Admitted Pro Hac Vice (paid $50 PHV fee; receipt number 1085-2057434) by Actavis LLC, Actavis PLC, Actavis Pharma, Inc., Cephalon Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., Watson Pharma, Inc., Watson Pharmaceuticals, Inc. [Note: Attorney Robert Garner McCampbell added to party Actavis PLC(pty:dft), Attorney Robert Garner McCampbell added to party Watson Pharma, Inc.(pty:dft), Attorney Robert Garner McCampbell added to party Watson Pharmaceuticals, Inc.(pty:dft).] (With attachments) (McCampbell, Robert) [Transferred from oknd on 6/10/2019.]
|
|
| 74 | 74
MOTION for Attorney(s) Steven Reed to be Admitted Pro Hac Vice (paid $50 PHV fee; receipt number 1085-2057435) by Actavis LLC, Actavis PLC, Actavis Pharma, Inc., Cephalon Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., Watson Pharma, Inc., Watson Pharmaceuticals, Inc. (With attachments) (McCampbell, Robert) [Transferred from oknd on 6/10/2019.]
|
|
| 75 | 75
MOTION for Attorney(s) Brian Ercole to be Admitted Pro Hac Vice (paid $50 PHV fee; receipt number 1085-2057436) by Actavis LLC, Actavis PLC, Actavis Pharma, Inc., Cephalon Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., Watson Pharma, Inc., Watson Pharmaceuticals, Inc. (With attachments) (McCampbell, Robert) [Transferred from oknd on 6/10/2019.]
|
|
| Tuesday, May 28, 2019 | ||
| 76 | 76
ORDER by Judge Terence Kern - Harvey Bartle, IV, Steven A. Reed and Brian M. Ercole are admitted Pro Hac Vice for Teva Defendants. ; ; granting73 Motion for Admission Pro Hac Vice; granting74 Motion for Admission Pro Hac Vice; granting75 Motion for Admission Pro Hac Vice (lmc, Chambers) [Transferred from oknd on 6/10/2019.]
|
|
| Wednesday, May 29, 2019 | ||
| 77 | 77 MINUTE ORDER by Court Clerk , directing Teva Pharmaceutical Industries, Ltd., Actavis PLC, Watson Pharmaceuticals, Inc., Watson Pharma, Inc. to file a Corporate Disclosure Statement pursuant to FRCvP 7.1 within seven (7) days of this order, if they have not already done so. The parties shall use the form entitled Corporate Disclosure Statement available on the Courts website (please do not refile if already filed on non-court form unless directed to do so). If you have already filed your Corporate Disclosure Statement in this case, you are reminded to file a Supplemental Corporate Disclosure Statement within a reasonable time of any change in the information that the statement requires. (This entry is the Official Order of the Court. No document is attached.) (dlg, Dpty Clk) [Transferred from oknd on 6/10/2019.] | |
| 78 | 78
MOTION to Withdraw Attorney(s) Tiffany M. Ikeda (With Notice of Motion to Withdraw) by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from oknd on 6/10/2019.]
|
|
| 79 | 79
ORDER by Judge Terence Kern ; terminating attorney Tiffany Ikeda ; granting78 Motion to Withdraw Attorney(s) (lmc, Chambers) [Transferred from oknd on 6/10/2019.]
|
|
| Wednesday, June 05, 2019 | ||
| 80 | 80
***Remark: Received Transfer Order from MDL re: Transfer (sc, Dpty Clk) [Transferred from oknd on 6/10/2019.]
|
|
| 81 | 81
MINUTE ORDER from MDL re: transferee clerk to transmit a certified copy of the Panel Order to transfer to the district court from which the action is being transferred (sc, Dpty Clk) [Transferred from oknd on 6/10/2019.]
|
|
| Thursday, June 06, 2019 | ||
| ***Civil Case Terminated (Documents Terminated:51 MOTION to Remand ,55 Joint MOTION to Stay Proceedings Pending Likely Transfer to Multidistrict Litigation ) (see document number82 ) (sac-qc, Dpty Clk) [Transferred from oknd on 6/10/2019.] | ||
| 82 | 82
ORDER by Sarah S. Vance, Acting Chair, Panel on Multidistrict Litigation , transferring case (sc, Dpty Clk) [Transferred from oknd on 6/10/2019.]
|
|
| Monday, June 10, 2019 | ||
| 83 | 83
CASE TRANSFERRED IN from District of Oklahoma Northern. Case number 4:19-cv-00047. Original file, certified copy of transfer order and docket sheet received.
|
|